This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Abdul Momin MHF, Bean DC, Hendriksen RS, Haenni M, Phee LM, Wareham DW. CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens. J Med Microbiol. 2017 Nov 01;66(11):1554–1561. https://doi.org/10.1099/jmm.0.000602Abdul MominMHFBeanDCHendriksenRSHaenniMPheeLMWarehamDW.CHROMagar COL-APSE: a selective bacterial culture medium for the isolation and differentiation of colistin-resistant Gram-negative pathogens. J Med Microbiol.2017Nov 01;66(11):1554–1561. https://doi.org/10.1099/jmm.0.00060210.1099/jmm.0.00060228984232Search in Google Scholar
AbuOun M, Stubberfield EJ, Duggett NA, Kirchner M, Dormer L, Nunez-Garcia J, Randall LP, Lemma F, Crook DW, Teale C, et al. mcr-1 and mcr-2 (mcr-6.1) variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015. J Anti microb Chemother. 2017 Oct 01;72(10):2745–2749. https://doi.org/10.1093/jac/dkx286AbuOunMStubberfieldEJDuggettNAKirchnerMDormerLNunez-GarciaJRandallLPLemmaFCrookDWTealeC, mcr-1 and mcr-2 (mcr-6.1) variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015. J Anti microb Chemother.2017Oct 01;72(10):2745–2749. https://doi.org/10.1093/jac/dkx28610.1093/jac/dkx286589071729091227Search in Google Scholar
AbuOun M, Stubberfield EJ, Duggett NA, Kirchner M, Dormer L, Nunez-Garcia J, Randall LP, Lemma F, Crook DW, Teale C, et al. mcr-1 and mcr-2 (mcr-6.1) variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015. J Anti microb Chemother. 2018 Oct 01;73(10):2904. https://doi.org/10.1093/jac/dky272AbuOunMStubberfieldEJDuggettNAKirchnerMDormerLNunez-GarciaJRandallLPLemmaFCrookDWTealeC, mcr-1 and mcr-2 (mcr-6.1) variant genes identified in Moraxella species isolated from pigs in Great Britain from 2014 to 2015. J Anti microb Chemother.2018Oct 01;73(10):2904. https://doi.org/10.1093/jac/dky27210.1093/jac/dky272614820730053008Search in Google Scholar
American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumo nia. Am J Respir Crit Care Med. 2005 Feb 15;171(4):388–416. https://doi.org/10.1164/rccm.200405-644STAmerican Thoracic Society; Infectious Diseases Society of America.Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumo nia. Am J Respir Crit Care Med.2005Feb 15;171(4):388–416. https://doi.org/10.1164/rccm.200405-644ST10.1164/rccm.200405-644ST15699079Search in Google Scholar
Antoniadou A, Kontopidou F, Poulakou G, Koratzanis E, Galani I, Papadomichelakis E, Kopterides P, Souli M, Armaganidis A, Giamarellou H. Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother. 2007 Apr 01;59(4):786–790. https://doi.org/10.1093/jac/dkl562AntoniadouAKontopidouFPoulakouGKoratzanisEGalaniIPapadomichelakisEKopteridesPSouliMArmaganidisAGiamarellouH.Colistin-resistant isolates of Klebsiella pneumoniae emerging in intensive care unit patients: first report of a multiclonal cluster. J Antimicrob Chemother.2007Apr 01;59(4):786–790. https://doi.org/10.1093/jac/dkl56210.1093/jac/dkl56217307769Search in Google Scholar
Baraniak A, Izdebski R, Fiett J, Gawryszewska I, Bojarska K, Herda M, Literacka E, Żabicka D, Tomczak H, Pewińska N, et al. NDM-producing Enterobacteriaceae in Poland, 2012–14: interregional outbreak of Klebsiella pneumoniae ST11 and sporadic cases. J Antimicrob Chemother. 2016 Jan;71(1):85–91. https://doi.org/10.1093/jac/dkv282BaraniakAIzdebskiRFiettJGawryszewskaIBojarskaKHerdaMLiterackaEŻabickaDTomczakHPewińskaN, NDM-producing Enterobacteriaceae in Poland, 2012–14: interregional outbreak of Klebsiella pneumoniae ST11 and sporadic cases. J Antimicrob Chemother.2016Jan;71(1):85–91. https://doi.org/10.1093/jac/dkv28210.1093/jac/dkv28226386745Search in Google Scholar
Bardet L, Le Page S, Leangapichart T, Rolain JM. LBJMR medium: a new polyvalent culture medium for isolating and selecting vanco mycin and colistin-resistant bacteria. BMC Microbiol. 2017 Dec; 17(1):220. https://doi.org/10.1186/s12866-017-1128-xBardetLLe PageSLeangapichartTRolainJM.LBJMR medium: a new polyvalent culture medium for isolating and selecting vanco mycin and colistin-resistant bacteria. BMC Microbiol.2017Dec; 17(1):220. https://doi.org/10.1186/s12866-017-1128-x10.1186/s12866-017-1128-x570143229169321Search in Google Scholar
Baron S, Hadjadj L, Rolain JM, Olaitan AO. Molecular mechanisms of polymyxin resistance: knowns and unknowns. Int J Antimicrob Agents. 2016 Dec;48(6):583–591. https://doi.org/10.1016/j.ijantimicag.2016.06.023BaronSHadjadjLRolainJMOlaitanAO.Molecular mechanisms of polymyxin resistance: knowns and unknowns. Int J Antimicrob Agents.2016Dec;48(6):583–591. https://doi.org/10.1016/j.ijantimicag.2016.06.02310.1016/j.ijantimicag.2016.06.02327524102Search in Google Scholar
Batirel A, Balkan II, Karabay O, Agalar C, Akalin S, Alici O, Alp E, Altay FA, Altin N, Arslan F, et al. Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections. Eur J Clin Microbiol Infect Dis. 2014 Aug;33(8):1311–1322. https://doi.org/10.1007/s10096-014-2070-6BatirelABalkanIIKarabayOAgalarCAkalinSAliciOAlpEAltayFAAltinNArslanF, Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections. Eur J Clin Microbiol Infect Dis.2014Aug;33(8):1311–1322. https://doi.org/10.1007/s10096-014-2070-610.1007/s10096-014-2070-624532009Search in Google Scholar
Behera B, Mathur P, Das A, Kapil A, Gupta B, Bhoi S, Farooque K, Sharma V, Misra MC. Evaluation of susceptibility testing methods for polymyxin. Int J Infect Dis. 2010 Jul;14(7):e596–e601. https://doi.org/10.1016/j.ijid.2009.09.001BeheraBMathurPDasAKapilAGuptaBBhoiSFarooqueKSharmaVMisraMC.Evaluation of susceptibility testing methods for polymyxin. Int J Infect Dis.2010Jul;14(7):e596–e601. https://doi.org/10.1016/j.ijid.2009.09.00110.1016/j.ijid.2009.09.00120045367Search in Google Scholar
Bernasconi OJ, Principe L, Tinguely R, Karczmarek A, Perreten V, Luzzaro F, Endimiani A. Evaluation of a new commercial microarray platform for the simultaneous detection of β-lactamase and mcr-1 and mcr-2 genes in Enterobacteriaceae. J Clin Microbiol. 2017 Oct;55(10):3138–3141. https://doi.org/10.1128/JCM.01056-17BernasconiOJPrincipeLTinguelyRKarczmarekAPerretenVLuzzaroFEndimianiA.Evaluation of a new commercial microarray platform for the simultaneous detection of β-lactamase and mcr-1 and mcr-2 genes in Enterobacteriaceae. J Clin Microbiol.2017Oct;55(10):3138–3141. https://doi.org/10.1128/JCM.01056-1710.1128/JCM.01056-17562540028768732Search in Google Scholar
Borck Høg B, Korsgaard HB, Wolff Sönksen U, Bager H, Bor atolaia V, Ellis-Iversen J, Hendriksen RS, Jensen LB, Korsgaard HB, Vorobieva V. DANMAP 2016 – Use of antimicrobial agents and occurrence of antimicrobial resistance inbacteria from food animals, food and humans in Denmark. Statens Serum Institut, National Veterinary Institute, Technical University of Denmark National Food Institute, Technical University of Denmark. 2017. https://orbit.dtu.dk/ws/files/161713656/Rapport_DANMAP_2017.pdfBorck HøgBKorsgaardHBWolff SönksenUBagerHBor atolaiaVEllis-IversenJHendriksenRSJensenLBKorsgaardHBVorobievaV.DANMAP 2016 – Use of antimicrobial agents and occurrence of antimicrobial resistance inbacteria from food animals, food and humans in Denmark. Statens Serum Institut, National Veterinary Institute, Technical University of Denmark National Food Institute, Technical University of Denmark. 2017. https://orbit.dtu.dk/ws/files/161713656/Rapport_DANMAP_2017.pdfSearch in Google Scholar
Borowiak M, Fischer J, Hammerl JA, Hendriksen RS, Szabo I, Malorny B. Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob Chemother. 2017 Dec 01;72(12):3317–3324. https://doi.org/10.1093/jac/dkx327BorowiakMFischerJHammerlJAHendriksenRSSzaboIMalornyB.Identification of a novel transposon-associated phosphoethanolamine transferase gene, mcr-5, conferring colistin resistance in d-tartrate fermenting Salmonella enterica subsp. enterica serovar Paratyphi B. J Antimicrob Chemother.2017Dec 01;72(12):3317–3324. https://doi.org/10.1093/jac/dkx32710.1093/jac/dkx32728962028Search in Google Scholar
Bos ME, Taverne FJ, van Geijlswijk IM, Mouton JW, Mevius DJ, Heederik DJ; Netherlands Veterinary Medicines Authority SDa. Consumption of antimicrobials in pigs, veal calves, and broilers in the Netherlands: quantitative results of nationwide collection of data in 2011. PLoS One. 2013 Oct 21;21;8(10):e77525. https://doi.org/10.1371/journal.pone.0077525BosMETaverneFJvan GeijlswijkIMMoutonJWMeviusDJHeederikDJ; Netherlands Veterinary Medicines Authority SDa.Consumption of antimicrobials in pigs, veal calves, and broilers in the Netherlands: quantitative results of nationwide collection of data in 2011. PLoS One.2013Oct 21;21;8(10):e77525. https://doi.org/10.1371/journal.pone.007752510.1371/journal.pone.0077525380457424204857Search in Google Scholar
Bosacka K, Kozińska A, Stefaniuk E, Rybicka J, Mikołajczyk A, Młodzińska E, Hryniewicz W. Colistin antimicrobial susceptibility testing of Gram-negative bacteria – evaluation of tests available in Poland. ECCMID 2018 Abstract publication E0116, 21–24 April 2018; Available from https://www.escmid.org/escmid_publications/escmid_elibrary/?q=Bosacka+K&id=2173&L=0&x=28&y=20BosackaKKozińskaAStefaniukERybickaJMikołajczykAMłodzińskaEHryniewiczW.Colistin antimicrobial susceptibility testing of Gram-negative bacteria – evaluation of tests available in Poland. ECCMID 2018 Abstract publication E0116, 21–24 April 2018; Available from https://www.escmid.org/escmid_publications/escmid_elibrary/?q=Bosacka+K&id=2173&L=0&x=28&y=20Search in Google Scholar
BTK. Guidelines for the prudent use of veterinary antimicrobial drugs – with notes for guidance. Federal Veterinary Surgeons’ Asso ciation (BTK = Bundestierärztekammer). Addendum to the German Veterinary Gazette 2015;(3/2015). Available from https://www.bundestieraerztekammer.de/tieraerzte/leitlinien/BTK.Guidelines for the prudent use of veterinary antimicrobial drugs – with notes for guidance. Federal Veterinary Surgeons’ Asso ciation (BTK = Bundestierärztekammer). Addendum to the German Veterinary Gazette 2015;(3/2015). Available from https://www.bundestieraerztekammer.de/tieraerzte/leitlinien/Search in Google Scholar
Capone A, Giannella M, Fortini D, Giordano A, Meledandri M, Ballardini M, Venditti M, Bordi E, Capozzi D, Balice MP, et al. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect. 2013 Jan;19(1):E23–E30., https://doi.org/10.1111/1469-0691.12070CaponeAGiannellaMFortiniDGiordanoAMeledandriMBallardiniMVendittiMBordiECapozziDBaliceMP, High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality. Clin Microbiol Infect.2013Jan;19(1):E23–E30., https://doi.org/10.1111/1469-0691.1207010.1111/1469-0691.1207023137235Search in Google Scholar
Carattoli A, Villa L, Feudi C, Curcio L, Orsini S, Luppi A, Pezzotti G, Magistrali CF. Novel plasmid-mediated colistin resistance gene mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Euro Surveill. 2017 Aug 3;22(31). https://doi.org/10.2807/1560-7917.ES.2017.22.31.30589CarattoliAVillaLFeudiCCurcioLOrsiniSLuppiAPezzottiGMagistraliCF.Novel plasmid-mediated colistin resistance gene mcr-4 gene in Salmonella and Escherichia coli, Italy 2013, Spain and Belgium, 2015 to 2016. Euro Surveill.2017Aug 3;22(31). https://doi.org/10.2807/1560-7917.ES.2017.22.31.3058910.2807/1560-7917.ES.2017.22.31.30589555306228797329Search in Google Scholar
Carroll LM, Gaballa A, Guldimann C, Sullivan G, Henderson LO, Wiedmann M. Identification of novel mobilized colistin resistance gene mcr-9 in a multidrug-resistant, colistin-susceptible Salmonella enterica serotype Typhimurium isolate. MBio. 2019;10(3): e00853-19. https://doi.org/10.1128/mBio.00853-19CarrollLMGaballaAGuldimannCSullivanGHendersonLOWiedmannM.Identification of novel mobilized colistin resistance gene mcr-9 in a multidrug-resistant, colistin-susceptible Salmonella enterica serotype Typhimurium isolate. MBio.2019;10(3): e00853-19. https://doi.org/10.1128/mBio.00853-1910.1128/mBio.00853-19650919431064835Search in Google Scholar
Casal J, Mateu E, Mejía W, Martín M. Factors associated with routine mass antimicrobial usage in fattening pig units in a high pig-density area. Vet Res. 2007 May;38(3):481–492. https://doi.org/10.1051/vetres:2007010CasalJMateuEMejíaWMartínM.Factors associated with routine mass antimicrobial usage in fattening pig units in a high pig-density area. Vet Res.2007May;38(3):481–492. https://doi.org/10.1051/vetres:200701010.1051/vetres:2007010Search in Google Scholar
Catry B, Cavaleri M, Baptiste K, Grave K, Grein K, Holm A, Jukes H, Liebana E, Navas AL, Mackay D, et al. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health. Int J Antimicrob Agents. 2015 Sep;46(3):297–306. https://doi.org/10.1016/j.ijantimicag.2015.06.005CatryBCavaleriMBaptisteKGraveKGreinKHolmAJukesHLiebanaENavasALMackayD, Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health. Int J Antimicrob Agents.2015Sep;46(3):297–306. https://doi.org/10.1016/j.ijantimicag.2015.06.00510.1016/j.ijantimicag.2015.06.00526215780Search in Google Scholar
Chew KL, La MV, Lin RTP, Teo JWP. Colistin and polymyxin B susceptibility testing for carbapenem-resistant and mcr-positive Enterobacteriaceae: comparison of sensititre, MicroScan, Vitek 2, and Etest with broth microdilution. J Clin Microbiol. 2017 Sep; 55(9):2609–2616. https://doi.org/10.1128/JCM.00268-17ChewKLLaMVLinRTPTeoJWP.Colistin and polymyxin B susceptibility testing for carbapenem-resistant and mcr-positive Enterobacteriaceae: comparison of sensititre, MicroScan, Vitek 2, and Etest with broth microdilution. J Clin Microbiol.2017Sep; 55(9):2609–2616. https://doi.org/10.1128/JCM.00268-1710.1128/JCM.00268-17564869828592552Search in Google Scholar
CLSI. Performance standards for antimicrobial susceptibility testing. 26th ed. CLSI supplement M100S. Wayane (PA): Clinical and Laboratory Standards Institute; 2016.CLSI.Performance standards for antimicrobial susceptibility testing. 26th ed. CLSI supplementM100S. Wayane (PA): Clinical and Laboratory Standards Institute; 2016.Search in Google Scholar
Dafopoulou K, Zarkotou O, Dimitroulia E, Hadjichristodoulou C, Gennimata V, Pournaras S, Tsakris A. Comparative evaluation of colistin susceptibility testing methods among carbapenem-non-susceptible Klebsiella pneumoniae and Acinetobacter bau mannii clinical isolates. Antimicrob Agents Chemother. 2015 Aug;59(8):4625–4630. https://doi.org/10.1128/AAC.00868-15DafopoulouKZarkotouODimitrouliaEHadjichristodoulouCGennimataVPournarasSTsakrisA.Comparative evaluation of colistin susceptibility testing methods among carbapenem-non-susceptible Klebsiella pneumoniae and Acinetobacter bau mannii clinical isolates. Antimicrob Agents Chemother.2015Aug;59(8):4625–4630. https://doi.org/10.1128/AAC.00868-1510.1128/AAC.00868-15450527026014928Search in Google Scholar
Das P, Sengupta K, Goel G, Bhattacharya S. Colistin: Pharma cology, drug resistance and clinical applications. J Acad Clin Microbiol. 2017;19(2):77–85. https://doi.org/10.4103/jacm.jacm_31_17DasPSenguptaKGoelGBhattacharyaS.Colistin: Pharma cology, drug resistance and clinical applications. J Acad Clin Microbiol.2017;19(2):77–85. https://doi.org/10.4103/jacm.jacm_31_1710.4103/jacm.jacm_31_17Search in Google Scholar
Davido B, Fellous L, Lawrence C, Maxime V, Rottman M, Dinh A. Ceftazidime-avibactam and aztreonam, an interesting strategy to overcome b-lactam resistance conferred by metallob-lactamases in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2017 Sep;61(9):e01008-17. https://doi.org/10.1128/AAC.01008-17DavidoBFellousLLawrenceCMaximeVRottmanMDinhA.Ceftazidime-avibactam and aztreonam, an interesting strategy to overcome b-lactam resistance conferred by metallob-lactamases in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother.2017Sep;61(9):e01008-17. https://doi.org/10.1128/AAC.01008-1710.1128/AAC.01008-17557132028630191Search in Google Scholar
Dzierżanowska D. Antybiotykoterapia praktyczna (in Polish). Bielsko-Biała (Poland): α-medica Press; 2018. p. 206–209.DzierżanowskaD.Antybiotykoterapia praktyczna (in Polish). Bielsko-Biała (Poland): α-medica Press; 2018. p. 206–209.Search in Google Scholar
ECDC. Antimicrobial Resistance Surveillance in Europe, 2013; Annual Report of the European Antimicrobial Resistance Surveil lance Network (EARS-Net). Stockholm (Sweden): European Centre for Disease Prevention and Control; 2014 [cited 2019 Jun 11]. Available from https://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2013ECDC.Antimicrobial Resistance Surveillance in Europe, 2013; Annual Report of the European Antimicrobial Resistance Surveil lance Network (EARS-Net). Stockholm (Sweden): European Centre for Disease Prevention and Control; 2014[cited 2019 Jun 11]. Available from https://ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2013Search in Google Scholar
EMA/CVMP. Opinion following an Article 35 referral for veteri nary medicinal formulations containing colistin at 2 000 000 IU per ml and intended for administration in drinking water to food producing species. Amsterdam (The Netherlands): European Medi cines Agency, Committee for Medical Products for Veterinary Use; 2010 [cited 2019 Jun 11]. Available from http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Colistin_25/WC500093733.pdf.EMA/CVMP.Opinion following an Article 35 referral for veteri nary medicinal formulations containing colistin at 2 000 000 IU per ml and intended for administration in drinking water to food producing species. Amsterdam (The Netherlands): European Medi cines Agency, Committee for Medical Products for Veterinary Use; 2010[cited 2019 Jun 11]. Available from http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Colistin_25/WC500093733.pdf.Search in Google Scholar
EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, 2016.; Basel (Switzerland): The European Committee on Antimicrobial Susceptibility Testing; 2016 [cited 2019 Jun 11]. Available from htpp://www.eucast.orgEUCAST.Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, 2016.; Basel (Switzerland): The European Committee on Antimicrobial Susceptibility Testing; 2016[cited 2019 Jun 11]. Available from htpp://www.eucast.orgSearch in Google Scholar
Falagas ME, Kasiakou SK, Saravolatz LD. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005 May 01;40(9):1333–1341. https://doi.org/10.1086/429323FalagasMEKasiakouSKSaravolatzLD.Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis.2005May 01;40(9):1333–1341. https://doi.org/10.1086/42932310.1086/42932315825037Search in Google Scholar
Gaibani P, Campoli C, Lewis RE, Volpe SL, Scaltriti E, Giannella M, Pongolini S, Berlingeri A, Cristini F, Bartoletti M, et al. In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment. J Antimicrob Chemother. 2018 Jun 01;73(6):1525–1529. https://doi.org/10.1093/jac/dky082GaibaniPCampoliCLewisREVolpeSLScaltritiEGiannellaMPongoliniSBerlingeriACristiniFBartolettiM, In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment. J Antimicrob Chemother.2018Jun 01;73(6):1525–1529. https://doi.org/10.1093/jac/dky08210.1093/jac/dky08229566151Search in Google Scholar
Galani I, Kontopidou F, Souli M, Rekatsina PD, Koratzanis E, Deliolanis J, Giamarellou H. Colistin susceptibility testing by Etest and disk diffusion methods. Int J Antimicrob Agents. 2008 May; 31(5):434–439. https://doi.org/10.1016/j.ijantimicag.2008.01.011GalaniIKontopidouFSouliMRekatsinaPDKoratzanisEDeliolanisJGiamarellouH.Colistin susceptibility testing by Etest and disk diffusion methods. Int J Antimicrob Agents.2008May; 31(5):434–439. https://doi.org/10.1016/j.ijantimicag.2008.01.01110.1016/j.ijantimicag.2008.01.01118328674Search in Google Scholar
Gao B, Li X, Yang F, Chen W, Zhao Y, Bai G, Zhang Z. Molecular epidemiology and riskfactors of ventilator-associated pneumonia infection caused by carbapenem-resistant Enterobacteriaceae. Front Pharmacol. 2019 Mar 22;10:262. https://doi.org/10.3389/fphar.2019.00262GaoBLiXYangFChenWZhaoYBaiGZhangZ.Molecular epidemiology and riskfactors of ventilator-associated pneumonia infection caused by carbapenem-resistant Enterobacteriaceae. Front Pharmacol.2019Mar 22;10:262. https://doi.org/10.3389/fphar.2019.0026210.3389/fphar.2019.00262643953230967778Search in Google Scholar
García-Fernández S, García-Castillo M, Ruiz-Garbajosa P, Moro sini MI, Bala Y, Zambardi G, Cantón R. Performance of CHROMID® Colistin R agar, a new chromogenic medium for screening of colistin-resistant Enterobacterales. Diagn Microbiol Infect Dis. 2019 Jan;93(1):1–4. https://doi.org/10.1016/j.diagmicrobio.2018.07.008García-FernándezSGarcía-CastilloMRuiz-GarbajosaPMoro siniMIBalaYZambardiGCantónR.Performance of CHROMID® Colistin R agar, a new chromogenic medium for screening of colistin-resistant Enterobacterales. Diagn Microbiol Infect Dis.2019Jan;93(1):1–4. https://doi.org/10.1016/j.diagmicrobio.2018.07.00810.1016/j.diagmicrobio.2018.07.00830097296Search in Google Scholar
Ghafur A, Vidyalakshimi PR, Murali A, Priyadarshini K, Thirunarayan MA. Emergence of Pan-drug resistance amongst gram negative bacteria! The First case series from India. J Microbiol Infect Dis. 2014 Sep 01;4(3):86–91. https://doi.org/10.5799/ahinjs.02.2014.03.0145GhafurAVidyalakshimiPRMuraliAPriyadarshiniKThirunarayanMA.Emergence of Pan-drug resistance amongst gram negative bacteria! The First case series from India. J Microbiol Infect Dis.2014Sep 01;4(3):86–91. https://doi.org/10.5799/ahinjs.02.2014.03.014510.5799/ahinjs.02.2014.03.0145Search in Google Scholar
Giske CG, Kahlmeter G. Colistin antimicrobial susceptibility testing – can the slow and challenging be replaced by the rapid and convenient? Clin Microbiol Infect. 2018 Feb;24(2):93–94. https://doi.org/10.1016/j.cmi.2017.10.007GiskeCGKahlmeterG.Colistin antimicrobial susceptibility testing – can the slow and challenging be replaced by the rapid and convenient?Clin Microbiol Infect.2018Feb;24(2):93–94. https://doi.org/10.1016/j.cmi.2017.10.00710.1016/j.cmi.2017.10.00729066400Search in Google Scholar
Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y; CNSE Working Group. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 2010 Nov 18; 15(46):19711.GrundmannHLivermoreDMGiskeCGCantonRRossoliniGMCamposJVatopoulosAGniadkowskiMTothAPfeiferYJarlierVCarmeliY; CNSE Working Group.Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill.2010Nov 18; 15(46):19711.10.2807/ese.15.46.19711-en21144429Search in Google Scholar
Guducuoglu H, Gursoy NC, Yakupogullari Y, Parlak M, Karasin G, Sunnetcioglu M, Otlu B. Hospital outbreak of a colistin-resistant, NDM-1- and OXA-48-producing Klebsiella pneumoniae: high mortality from pandrug resistance. Microb Drug Resist. 2018 Sep;24(7):966–972. https://doi.org/10.1089/mdr.2017.0173GuducuogluHGursoyNCYakupogullariYParlakMKarasinGSunnetciogluMOtluB.Hospital outbreak of a colistin-resistant, NDM-1- and OXA-48-producing Klebsiella pneumoniae: high mortality from pandrug resistance. Microb Drug Resist.2018Sep;24(7):966–972. https://doi.org/10.1089/mdr.2017.017310.1089/mdr.2017.017329265963Search in Google Scholar
Gundogdu A, Ulu-Kilic A, Kilic H, Ozhan E, Altun D, Cakir O, Alp E. Could frequent carbapenem use be a risk factor for colistin resistance? Microb Drug Resist. 2018 Jul;24(6):774–781. https://doi.org/10.1089/mdr.2016.0321GundogduAUlu-KilicAKilicHOzhanEAltunDCakirOAlpE.Could frequent carbapenem use be a risk factor for colistin resistance?Microb Drug Resist.2018Jul;24(6):774–781. https://doi.org/10.1089/mdr.2016.032110.1089/mdr.2016.032129028174Search in Google Scholar
Humphries RM. Susceptibility testing of the polymyxins: where are we now? Pharmacotherapy. 2015 Jan;35(1):22–27. https://doi.org/10.1002/phar.1505HumphriesRM.Susceptibility testing of the polymyxins: where are we now?Pharmacotherapy.2015Jan;35(1):22–27. https://doi.org/10.1002/phar.150510.1002/phar.150525329490Search in Google Scholar
Izdebski R, Baraniak A, Bojarska K, Urbanowicz P, Fiett J, Pomor ska-Wesołowska M, Hryniewicz W, Gniadkowski M, Żabicka D. Mobile MCR-1-associated resistance to colistin in Poland: Table 1. J Antimicrob Chemother. 2016 Aug;71(8):2331–2333. https://doi.org/10.1093/jac/dkw261IzdebskiRBaraniakABojarskaKUrbanowiczPFiettJPomor ska-WesołowskaMHryniewiczWGniadkowskiMŻabickaD.Mobile MCR-1-associated resistance to colistin in Poland: Table 1. J Antimicrob Chemother.2016Aug;71(8):2331–2333. https://doi.org/10.1093/jac/dkw26110.1093/jac/dkw26127330064Search in Google Scholar
Jayol A, Nordmann P, Brink A, Poirel L. Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system. Antimicrob Agents Chemother. 2015 May;59(5):2780–2784. https://doi.org/10.1128/AAC.05055-14JayolANordmannPBrinkAPoirelL.Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system. Antimicrob Agents Chemother.2015May;59(5):2780–2784. https://doi.org/10.1128/AAC.05055-1410.1128/AAC.05055-14439480625733503Search in Google Scholar
Jayol A, Nordmann P, Poirel L, Dubois V. Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resis tant and carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2018 Feb 01;73(2):542–544. https://doi.org/10.1093/jac/dkx393JayolANordmannPPoirelLDuboisV.Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resis tant and carbapenemase-producing Klebsiella pneumoniae. J Antimicrob Chemother.2018Feb 01;73(2):542–544. https://doi.org/10.1093/jac/dkx39310.1093/jac/dkx39329165563Search in Google Scholar
Jayol A, Poirel L, André C, Dubois V, Nordmann P. Detection of colistin-resistant Gram-negative rods by using the SuperPolymyxin medium. Diagn Microbiol Infect Dis. 2018 Oct;92(2):95–101. https://doi.org/10.1016/j.diagmicrobio.2018.05.008JayolAPoirelLAndréCDuboisVNordmannP.Detection of colistin-resistant Gram-negative rods by using the SuperPolymyxin medium. Diagn Microbiol Infect Dis.2018Oct;92(2):95–101. https://doi.org/10.1016/j.diagmicrobio.2018.05.00810.1016/j.diagmicrobio.2018.05.00829885757Search in Google Scholar
Jayol A, Poirel L, Dortet L, Nordmann P. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014. Euro Surveill. 2016; 21(37):30339. https://doi.org/10.2807/1560-7917.ES.2016.21.37.30339JayolAPoirelLDortetLNordmannP.National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014. Euro Surveill.2016; 21(37):30339. https://doi.org/10.2807/1560-7917.ES.2016.21.37.3033910.2807/1560-7917.ES.2016.21.37.30339503285427685838Search in Google Scholar
Jones-Dias D, Manageiro V, Ferreira E, Barreiro P, Vieira L, Moura IB, Caniça M. Architecture of class 1, 2, and 3 integrons from Gram negative bacteria recovered among fruits and vegetables. Front Microbiol. 2016;7:1400. https://doi.org/10.3389/fmicb.2016.01400Jones-DiasDManageiroVFerreiraEBarreiroPVieiraLMouraIBCaniçaM.Architecture of class 1, 2, and 3 integrons from Gram negative bacteria recovered among fruits and vegetables. Front Microbiol.2016;7:1400. https://doi.org/10.3389/fmicb.2016.0140010.3389/fmicb.2016.01400502009227679611Search in Google Scholar
Jordan D, Chin JJ-C, Fahy VA, Barton MD, Smith MG, Trott DJ. Antimicrobial use in the Australian pig industry: results of a national survey. Aust Vet J. 2009 Jun;87(6):222–229. https://doi.org/10.1111/j.1751-0813.2009.00430.xJordanDChin JJ-C, FahyVABartonMDSmithMGTrottDJ.Antimicrobial use in the Australian pig industry: results of a national survey. Aust Vet J.2009Jun;87(6):222–229. https://doi.org/10.1111/j.1751-0813.2009.00430.x10.1111/j.1751-0813.2009.00430.x19489779Search in Google Scholar
Jung Y, Jang H, Matthews KR. Effect of the food production chain from farm practices to vegetable processing on outbreak incidence. Microb Biotechnol. 2014 Nov;7(6):517–527. https://doi.org/10.1111/1751-7915.12178JungYJangHMatthewsKR.Effect of the food production chain from farm practices to vegetable processing on outbreak incidence. Microb Biotechnol.2014Nov;7(6):517–527. https://doi.org/10.1111/1751-7915.1217810.1111/1751-7915.12178Search in Google Scholar
Kempf I, Fleury MA, Drider D, Bruneau M, Sanders P, Chauvin C, Madec JY, Jouy E. What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe? Int J Antimicrob Agents. 2013 Nov;42(5):379–383. https://doi.org/10.1016/j.ijantimicag.2013.06.012KempfIFleuryMADriderDBruneauMSandersPChauvinCMadecJYJouyE.What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe?Int J Antimicrob Agents.2013Nov;42(5):379–383. https://doi.org/10.1016/j.ijantimicag.2013.06.01210.1016/j.ijantimicag.2013.06.012Search in Google Scholar
Kim DP, Saegerman C, Douny C, Dinh TV, Xuan BH, Vu BD, Hong NP, Scippo M-L. First survey on the use of antibiotics in pig and poultry production in the Red River Delta region of Vietnam. Food Public Health. 2013;3(5):247–256. https://doi.org/10.5923/j.fph.20130305.03KimDPSaegermanCDounyCDinhTVXuanBHVuBDHongNPScippoM-L.First survey on the use of antibiotics in pig and poultry production in the Red River Delta region of Vietnam. Food Public Health.2013;3(5):247–256. https://doi.org/10.5923/j.fph.20130305.03Search in Google Scholar
Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970 Jun 01;72(6):857–868. https://doi.org/10.7326/0003-4819-72-6-857Koch-WeserJSidelVWFedermanEBKanarekPFinerDCEatonAE.Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med.1970Jun 01;72(6):857–868. https://doi.org/10.7326/0003-4819-72-6-85710.7326/0003-4819-72-6-857Search in Google Scholar
Kostowski W, Herman ZS. Farmakologia (in Polish). Warsaw (Poland): PZWL Press; 2010. p. 341–342.KostowskiWHermanZS.Farmakologia (in Polish). Warsaw (Poland): PZWL Press; 2010. p. 341–342.Search in Google Scholar
Kwa ALH, Loh C, Low JGH, Kurup A, Tam VH. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis. 2005 Sep 01;41(5):754–757. https://doi.org/10.1086/432583KwaALHLohCLowJGHKurupATamVH.Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis.2005Sep 01;41(5):754–757. https://doi.org/10.1086/43258310.1086/432583Search in Google Scholar
Kwon JA, Lee JE, Huh W, Peck KR, Kim YG, Kim DJ, Oh HY. Predictors of acute kidney injury associated with intravenous colistin treatment. Int J Antimicrob Agents. 2010 May;35(5):473–477. https://doi.org/10.1016/j.ijantimicag.2009.12.002KwonJALeeJEHuhWPeckKRKimYGKimDJOhHY.Predictors of acute kidney injury associated with intravenous colistin treatment. Int J Antimicrob Agents.2010May;35(5):473–477. https://doi.org/10.1016/j.ijantimicag.2009.12.00210.1016/j.ijantimicag.2009.12.002Search in Google Scholar
Lellouche J, Schwartz D, Elmalech N, Ben Dalak MA, Temkin E, Paul M, Geffen Y, Yahav D, Eliakim-Raz N, Durante-Mangoni E, et al.; AIDA study group. Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility. Clin Microbiol Infect. 2019 Jun;25(6):711–716. https://doi.org/10.1016/j.cmi.2018.09.014LelloucheJSchwartzDElmalechNBen DalakMATemkinEPaulMGeffenYYahavDEliakim-RazNDurante-MangoniEAIDA study group.Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility. Clin Microbiol Infect.2019Jun;25(6):711–716. https://doi.org/10.1016/j.cmi.2018.09.01410.1016/j.cmi.2018.09.014Search in Google Scholar
Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2005 Jan;25(1):11–25. https://doi.org/10.1016/j.ijantimicag.2004.10.001LiJNationRLMilneRWTurnidgeJDCoulthardK.Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents.2005Jan;25(1):11–25. https://doi.org/10.1016/j.ijantimicag.2004.10.00110.1016/j.ijantimicag.2004.10.001Search in Google Scholar
Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR, Paterson DL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006 Sep;6(9):589–601. https://doi.org/10.1016/S1473-3099(06)70580-1LiJNationRLTurnidgeJDMilneRWCoulthardKRaynerCRPatersonDL.Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis.2006Sep;6(9):589–601. https://doi.org/10.1016/S1473-3099(06)70580-110.1016/S1473-3099(06)70580-1Search in Google Scholar
Li J. Difficulty in assaying colistin methanesulphonate. Clin Microbiol Infect. 2005 Sep;11(9):773–774. https://doi.org/10.1111/j.1469-0691.2005.01218.xLiJ.Difficulty in assaying colistin methanesulphonate. Clin Microbiol Infect.2005Sep;11(9):773–774. https://doi.org/10.1111/j.1469-0691.2005.01218.x10.1111/j.1469-0691.2005.01218.x16104997Search in Google Scholar
Li R, Xie M, Zhang J, Yang Z, Liu L, Liu X, Zheng Z, Chan EWC, Chen S. Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant. J Antimicrob Chemother. 2017 Feb;72(2):393–401. https://doi.org/10.1093/jac/dkw411LiRXieMZhangJYangZLiuLLiuXZhengZChanEWCChenS.Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant. J Antimicrob Chemother.2017Feb;72(2):393–401. https://doi.org/10.1093/jac/dkw41110.1093/jac/dkw41128073961Search in Google Scholar
Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski A 3rd, Forrest A, Bulitta JB, Tsuji BT. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy. 2010 Dec;30(12):1279–1291. https://doi.org/10.1592/phco.30.12.1279LimLMLyNAndersonDYangJCMacanderLJarkowskiA3rdForrestABulittaJBTsujiBT.Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy.2010Dec;30(12):1279–1291. https://doi.org/10.1592/phco.30.12.127910.1592/phco.30.12.1279Search in Google Scholar
Liu B-T, Li X, Zhang Q, Shan H, Zou M, Song F-J. Colistin-resistant mcr-positive Enterobacteriaceae in fresh vegetables, an increasing infectious threat in China. Int J Antimicrob Agents. 2019;54(1):89–94. https://doi.org/10.1016/j.ijantimicag.2019.04.013Liu B-T, LiXZhangQShanHZouMSongF-J.Colistin-resistant mcr-positive Enterobacteriaceae in fresh vegetables, an increasing infectious threat in China. Int J Antimicrob Agents.2019;54(1):89–94. https://doi.org/10.1016/j.ijantimicag.2019.04.01310.1016/j.ijantimicag.2019.04.013Search in Google Scholar
Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, Doi Y, Tian G, Dong B, Huang X, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016 Feb;16(2):161–168. https://doi.org/10.1016/S1473-3099(15)00424-7LiuYYWangYWalshTRYiLXZhangRSpencerJDoiYTianGDongBHuangX, Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis.2016Feb;16(2):161–168. https://doi.org/10.1016/S1473-3099(15)00424-710.1016/S1473-3099(15)00424-7Search in Google Scholar
Lomovskaya O, Sun D, Rubio-Aparicio D, Nelson K, Tsivkovski R, Griffith DC, Dudley MN. Vaborbactam: spectrum of beta-lactamase inhibition and impact of resistance mechanisms on activity in Enterobacteriaceae. Antimicrob Agents Chemother. 2017 Nov;61(11):e01443-17. https://doi.org/10.1128/AAC.01443-17LomovskayaOSunDRubio-AparicioDNelsonKTsivkovskiRGriffithDCDudleyMN.Vaborbactam: spectrum of beta-lactamase inhibition and impact of resistance mechanisms on activity in Enterobacteriaceae. Antimicrob Agents Chemother.2017Nov;61(11):e01443-17. https://doi.org/10.1128/AAC.01443-1710.1128/AAC.01443-17565509828848018Search in Google Scholar
Luo J, Yao X, Lv L, Doi Y, Huang X, Huang S, Liu JH. Emergence of mcr-1 in Raoultella ornithinolytica and Escherichia coli isolates from retail vegetables in China. Antimicrob Agents Chemother. 2017 Oct;61(10):e01139-17. https://doi.org/10.1128/AAC.01139-17LuoJYaoXLvLDoiYHuangXHuangSLiuJH.Emergence of mcr-1 in Raoultella ornithinolytica and Escherichia coli isolates from retail vegetables in China. Antimicrob Agents Chemother.2017Oct;61(10):e01139-17. https://doi.org/10.1128/AAC.01139-1710.1128/AAC.01139-17561053128739785Search in Google Scholar
MARAN. NethMap 2019: Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands/MARAN 2019: Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2018. Wageningen (The Netherlands): Wageningen University & Research; 2019 [cited 2019 Jun 11]. Available from https://www.wur.nl/upload_mm/a/7/9/89640bbc-53a2-40f0-ba4a-a9a34a7bf416_Nethmap%20Maran%202019.pdfMARAN.NethMap 2019: Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands/MARAN 2019: Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2018. Wageningen (The Netherlands): Wageningen University & Research; 2019[cited 2019 Jun 11]. Available from https://www.wur.nl/upload_mm/a/7/9/89640bbc-53a2-40f0-ba4a-a9a34a7bf416_Nethmap%20Maran%202019.pdfSearch in Google Scholar
Marchaim D, Chopra T, Pogue JM, Perez F, Hujer AM, Rudin S, Endimiani A, Navon-Venezia S, Hothi J, Slim J, et al. Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother. 2011 Feb;55(2):593–599. https://doi.org/10.1128/AAC.01020-10MarchaimDChopraTPogueJMPerezFHujerAMRudinSEndimianiANavon-VeneziaSHothiJSlimJ, Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan. Antimicrob Agents Chemother.2011Feb;55(2):593–599. https://doi.org/10.1128/AAC.01020-1010.1128/AAC.01020-10302879421115786Search in Google Scholar
MARD (Ministry of Agriculture and Rural Development). 2009. Livestock development strategy to 2020, Amendedand Reprinted in the first time. Publishing House for Scienceand Technology.MARD (Ministry of Agriculture and Rural Development). 2009. Livestock development strategy to 2020, Amendedand Reprinted in the first time. Publishing House for Scienceand Technology.Search in Google Scholar
MARD. (Ministry of Agriculture and Rural Development). Standard TCN. 2006;861:2006. [Animal feeding stuffs – Maximum levels of antibiotics and drugs in complete feed.].MARD. (Ministry of Agriculture and Rural Development). Standard TCN.2006;861:2006. [Animal feeding stuffs – Maximum levels of antibiotics and drugs in complete feed.].Search in Google Scholar
Matuschek E, Åhman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acine tobacter spp. Clin Microbiol Infect. 2018a Aug;24(8):865–870. https://doi.org/10.1016/j.cmi.2017.11.020MatuschekEÅhmanJWebsterCKahlmeterG.Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acine tobacter spp. Clin Microbiol Infect.2018aAug;24(8):865–870. https://doi.org/10.1016/j.cmi.2017.11.02010.1016/j.cmi.2017.11.02029221995Search in Google Scholar
Matuschek E, Davies L, Ahman J, Kahlmeter G, Wootton M. Can agar dilution be used for colistin MIC determination? Session: Colistin antimicrobial susceptibility testing – which methods are available? ECCMID 2018, 24 April 2018, Abstract publication O0954. 2018b [cited 2019 Jun 11]. Available from https://www.escmid.org/escmid_publications/escmid_elibrary/?q=Matuschek +E&id=2173&L=0&x=21&y=24MatuschekEDaviesLAhmanJKahlmeterGWoottonM.Can agar dilution be used for colistin MIC determination? Session: Colistin antimicrobial susceptibility testing – which methods are available?ECCMID 2018, 24 April 2018, Abstract publication O0954. 2018b [cited 2019 Jun 11]. Available from https://www.escmid.org/escmid_publications/escmid_elibrary/?q=Matuschek +E&id=2173&L=0&x=21&y=24Search in Google Scholar
Meletis G, Oustas E, Botziori C, Kakasi E, Koteli A. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance. New Microbiol. 2015 Jul;38(3):417–421.MeletisGOustasEBotzioriCKakasiEKoteliA.Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance. New Microbiol.2015Jul;38(3):417–421.Search in Google Scholar
Moffatt JH, Harper M, Harrison P, Hale JD, Vinogradov E, Seemann T, Henry R, Crane B, St Michael F, Cox AD, et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010;54(12):4971–4977. https://doi.org/10.1128/AAC.00834-10MoffattJHHarperMHarrisonPHaleJDVinogradovESeemannTHenryRCraneBSt MichaelFCoxAD, Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother.2010;54(12):4971–4977. https://doi.org/10.1128/AAC.00834-1010.1128/AAC.00834-10298123820855724Search in Google Scholar
Monaco M, Giani T, Raffone M, Arena F, Garcia-Fernandez A, Pollini S; Network EuSCAPE-Italy, Grundmann H, Pantosti A, Rossolini GM. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving pro blem in Italy, November 2013 to April 2014. Euro Surveill. 2014;19(42): 20939. https://doi.org/10.2807/1560-7917.es2014.19.42.20939MonacoMGianiTRaffoneMArenaFGarcia-FernandezAPollini S; Network EuSCAPE-Italy, GrundmannHPantostiARossoliniGM.Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving pro blem in Italy, November 2013 to April 2014. Euro Surveill.2014;19(42): 20939. https://doi.org/10.2807/1560-7917.es2014.19.42.2093910.2807/1560-7917.ES2014.19.42.20939Search in Google Scholar
Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis. 2009 Dec;22(6):535–543. https://doi.org/10.1097/QCO.0b013e328332e672NationRLLiJ.Colistin in the 21st century. Curr Opin Infect Dis.2009Dec;22(6):535–543. https://doi.org/10.1097/QCO.0b013e328332e67210.1097/QCO.0b013e328332e672286907619797945Search in Google Scholar
Nordmann P, Jayol A, Poirel L. A universal culture medium for screening polymyxin-resistant Gram-negative isolates. J Clin Microbiol. 2016 May;54(5):1395–1399. https://doi.org/10.1128/JCM.00446-16NordmannPJayolAPoirelL.A universal culture medium for screening polymyxin-resistant Gram-negative isolates. J Clin Microbiol.2016May;54(5):1395–1399. https://doi.org/10.1128/JCM.00446-1610.1128/JCM.00446-16484472826984971Search in Google Scholar
Nordmann P, Jayol A, Poirel L. Rapid detection of polymyxin resistance in Enterobacteriaceae. Emerg Infect Dis. 2016 Jun;22(6):1038–1043. https://doi.org/10.3201/eid2206.151840NordmannPJayolAPoirelL.Rapid detection of polymyxin resistance in Enterobacteriaceae. Emerg Infect Dis.2016Jun;22(6):1038–1043. https://doi.org/10.3201/eid2206.15184010.3201/eid2206.151840488007227191712Search in Google Scholar
Nunan C, Young R. Use of antibiotics in animals and people. Vet Rec. 2015 Nov 07;177(18):468.2–470. https://doi.org/10.1136/vr.h5934NunanCYoungR.Use of antibiotics in animals and people. Vet Rec.2015Nov 07;177(18):468.2–470. https://doi.org/10.1136/vr.h593410.1136/vr.h593426543216Search in Google Scholar
Olaitan AO, Diene SM, Kempf M, Berrazeg M, Bakour S, Gupta SK, Thongmalayvong B, Akkhavong K, Somphavong S, Paboriboune P, et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents. 2014 Dec;44(6):500–507. https://doi.org/10.1016/j.ijantimicag.2014.07.020OlaitanAODieneSMKempfMBerrazegMBakourSGuptaSKThongmalayvongBAkkhavongKSomphavongSPaboribouneP, Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents.2014Dec;44(6):500–507. https://doi.org/10.1016/j.ijantimicag.2014.07.02010.1016/j.ijantimicag.2014.07.02025264127Search in Google Scholar
Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014 Nov 26;5:643. https://doi.org/10.3389/fmicb.2014.00643OlaitanAOMorandSRolainJM.Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol.2014Nov 26;5:643. https://doi.org/10.3389/fmicb.2014.0064310.3389/fmicb.2014.00643424453925505462Search in Google Scholar
Ordooei Javan A, Shokouhi S, Sahraei Z. A review on colistin nephrotoxicity. Eur J Clin Pharmacol. 2015 Jul;71(7):801–810. https://doi.org/10.1007/s00228-015-1865-4Ordooei JavanAShokouhiSSahraeiZ.A review on colistin nephrotoxicity. Eur J Clin Pharmacol.2015Jul;71(7):801–810. https://doi.org/10.1007/s00228-015-1865-410.1007/s00228-015-1865-426008213Search in Google Scholar
Parisi SG, Bartolini A, Santacatterina E, Castellani E, Ghirardo R, Berto A, Franchin E, Menegotto N, De Canale E, Tommasini T, et al. Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014. BMC Infect Dis. 2015 Dec;15(1):244. https://doi.org/10.1186/s12879-015-0996-7ParisiSGBartoliniASantacatterinaECastellaniEGhirardoRBertoAFranchinEMenegottoNDe CanaleETommasiniT, Prevalence of Klebsiella pneumoniae strains producing carbapenemases and increase of resistance to colistin in an Italian teaching hospital from January 2012 To December 2014. BMC Infect Dis.2015Dec;15(1):244. https://doi.org/10.1186/s12879-015-0996-710.1186/s12879-015-0996-7448216626116560Search in Google Scholar
Pena I, Picazo JJ, Rodríguez-Avial C, Rodríguez-Avial I. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents. 2014 May;43(5):460–464. https://doi.org/10.1016/j.ijantimicag.2014.01.021PenaIPicazoJJRodríguez-AvialCRodríguez-AvialI.Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates. Int J Antimicrob Agents.2014May;43(5):460–464. https://doi.org/10.1016/j.ijantimicag.2014.01.02110.1016/j.ijantimicag.2014.01.02124657043Search in Google Scholar
Petrosillo N, Taglietti F, Granata G. Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future. J Clin Med. 2019;28;8(7):E934. https://doi.org/10.3390/jcm8070934PetrosilloNTagliettiFGranataG.Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future. J Clin Med.2019;28;8(7):E934. https://doi.org/10.3390/jcm807093410.3390/jcm8070934667846531261755Search in Google Scholar
Pfaller MA, Huband MD, Mendes RE, Flamm RK, Castanheira M. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme. Int J Antimicrob Agents. 2018 Aug;52(2):144–150. https://doi.org/10.1016/j.ijantimicag.2018.02.021PfallerMAHubandMDMendesREFlammRKCastanheiraM.In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme. Int J Antimicrob Agents.2018Aug;52(2):144–150. https://doi.org/10.1016/j.ijantimicag.2018.02.02110.1016/j.ijantimicag.2018.02.02129510189Search in Google Scholar
Pogue JM, Bonomo RA, Kaye KS. Ceftazidime/avibactam, meropenem/vaborbactam, or both? Clinical and formulary consi derations. Clin Infect Dis. 2019 Jan 18;68(3):519–524. https://doi.org/10.1093/cid/ciy576PogueJMBonomoRAKayeKS.Ceftazidime/avibactam, meropenem/vaborbactam, or both? Clinical and formulary consi derations. Clin Infect Dis.2019Jan 18;68(3):519–524. https://doi.org/10.1093/cid/ciy57610.1093/cid/ciy57630020449Search in Google Scholar
Pogue JM, Lee J, Marchaim D, Yee V, Zhao JJ, Chopra T, Lephart P, Kaye KS. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis. 2011 Nov 01;53(9):879–884. https://doi.org/10.1093/cid/cir611PogueJMLeeJMarchaimDYeeVZhaoJJChopraTLephartPKayeKS.Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis.2011Nov 01;53(9):879–884. https://doi.org/10.1093/cid/cir61110.1093/cid/cir61121900484Search in Google Scholar
Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017 Apr;30(2):557–596. https://doi.org/10.1128/CMR.00064-16PoirelLJayolANordmannP.Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev.2017Apr;30(2):557–596. https://doi.org/10.1128/CMR.00064-1610.1128/CMR.00064-16535564128275006Search in Google Scholar
QYResearch Medical Research Centre. The global polymyxin industry report 2015. Ottawa (Canada): QYResearch Medical Research Centre; 2015 [cited 2019 Jun 11]. Available from http://www.qyresearch.comQYResearch Medical Research Centre.The global polymyxin industry report 2015. Ottawa (Canada): QYResearch Medical Research Centre; 2015[cited 2019 Jun 11]. Available from http://www.qyresearch.comSearch in Google Scholar
Sandri AM, Landersdorfer CB, Jacob J, Boniatti MM, Dalarosa MG, Falci DR, Behle TF, Bordinhão RC, Wang J, Forrest A, et al. Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin Infect Dis. 2013 Aug 15;57(4):524–531. https://doi.org/10.1093/cid/cit334SandriAMLandersdorferCBJacobJBoniattiMMDalarosaMGFalciDRBehleTFBordinhãoRCWangJForrestA, Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens. Clin Infect Dis.2013Aug 15;57(4):524–531. https://doi.org/10.1093/cid/cit33410.1093/cid/cit33423697744Search in Google Scholar
Schindler M, Osborn MJ. Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry. 1979 Oct 02;18(20):4425–4430. https://doi.org/10.1021/bi00587a024SchindlerMOsbornMJ.Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry.1979Oct 02;18(20):4425–4430. https://doi.org/10.1021/bi00587a02410.1021/bi00587a024226126Search in Google Scholar
SDa Autoriteit Diergeneesmiddelen. Usage of antibiotics in agricultural livestock in the Netherlands in 2017. Trends and benchmarking of livestock farms and veterinarians. Utreht (The Netherlands): SDa Autoriteit Diergeneesmiddelen; 2018 [cited 2019 Jun 11]. Available from https://www.autoriteitdiergeneesmiddelen.nl/en/publicationsSDa Autoriteit Diergeneesmiddelen.Usage of antibiotics in agricultural livestock in the Netherlands in 2017. Trends and benchmarking of livestock farms and veterinarians. Utreht (The Netherlands): SDa Autoriteit Diergeneesmiddelen; 2018[cited 2019 Jun 11]. Available from https://www.autoriteitdiergeneesmiddelen.nl/en/publicationsSearch in Google Scholar
Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, et al. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother. 2017 Mar; 61(3):e02097-16. https://doi.org/10.1128/AAC.02097-16ShieldsRKChenLChengSChavdaKDPressEGSnyderAPandeyRDoiYKreiswirthBNNguyenMH, Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother.2017Mar; 61(3):e02097-16. https://doi.org/10.1128/AAC.02097-1610.1128/AAC.02097-16532854228031201Search in Google Scholar
Shields RK, Clancy CJ, Hao B, Chen L, Press EG, Iovine NM, Kreiswirth BN, Nguyen MH. Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae. Antimicrob Agents Chemother. 2015 Sep;59(9):5793–5797. https://doi.org/10.1128/AAC.00548-15ShieldsRKClancyCJHaoBChenLPressEGIovineNMKreiswirthBNNguyenMH.Effects of Klebsiella pneumoniae carbapenemase subtypes, extended-spectrum β-lactamases, and porin mutations on the in vitro activity of ceftazidime-avibactam against carbapenem-resistant K. pneumoniae. Antimicrob Agents Chemother.2015Sep;59(9):5793–5797. https://doi.org/10.1128/AAC.00548-1510.1128/AAC.00548-15453854726169413Search in Google Scholar
Sjölund M, Backhans A, Greko C, Emanuelson U, Lindberg A. Antimicrobial usage in 60 Swedish farrow-to-finish pig herds. Prev Vet Med. 2015 Oct;121(3-4):257–264. https://doi.org/10.1016/j.prevetmed.2015.07.005SjölundMBackhansAGrekoCEmanuelsonULindbergA.Antimicrobial usage in 60 Swedish farrow-to-finish pig herds. Prev Vet Med.2015Oct;121(3-4):257–264. https://doi.org/10.1016/j.prevetmed.2015.07.00510.1016/j.prevetmed.2015.07.00526211838Search in Google Scholar
Spapen H, Jacobs R, Van Gorp V, Troubleyn J, Honoré PM. Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care. 2011 Dec;1(1):14. https://doi.org/10.1186/2110-5820-1-14SpapenHJacobsRVan GorpVTroubleynJHonoréPM.Renal and neurological side effects of colistin in critically ill patients. Ann Intensive Care.2011Dec;1(1):14. https://doi.org/10.1186/2110-5820-1-1410.1186/2110-5820-1-14322447521906345Search in Google Scholar
SWEDRES/SVARM. Consumption of antibiotics and occurrence of antibiotic resistance in Sweden. Solna/Uppsala (Sweden): Public Health Agency of Sweden and National Veterinary Institute; 2018 [cited 2019 Jun 11]. Available from https://www.folkhalsomyn-digheten.se/contentassets/d8f6b3d187a94682a1d50a48f0a4fb3d/swedres-svarm-2018.pdfSWEDRES/SVARM.Consumption of antibiotics and occurrence of antibiotic resistance in Sweden.Solna/Uppsala (Sweden): Public Health Agency of Sweden and National Veterinary Institute; 2018[cited 2019 Jun 11]. Available from https://www.folkhalsomyn-digheten.se/contentassets/d8f6b3d187a94682a1d50a48f0a4fb3d/swedres-svarm-2018.pdfSearch in Google Scholar
Trauffler M, Griesbacher A, Fuchs K, Köfer J. Antimicrobial drug use in Austrian pig farms: plausibility check of electronic onfarm records and estimation of consumption. Vet Rec. 2014 Oct 25;175(16):402. https://doi.org/10.1136/vr.102520TraufflerMGriesbacherAFuchsKKöferJ.Antimicrobial drug use in Austrian pig farms: plausibility check of electronic onfarm records and estimation of consumption. Vet Rec.2014Oct 25;175(16):402. https://doi.org/10.1136/vr.10252010.1136/vr.102520421527525053268Search in Google Scholar
Tullu MS, Dhariwal AK. Colistin: re-emergence of the ‘forgotten’ antimicrobial agent. J Postgrad Med. 2013;59(3):208–215. https://doi.org/10.4103/0022-3859.118040TulluMSDhariwalAK.Colistin: re-emergence of the ‘forgotten’ antimicrobial agent. J Postgrad Med.2013;59(3):208–215. https://doi.org/10.4103/0022-3859.11804010.4103/0022-3859.11804024029199Search in Google Scholar
Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, Losito AR, Bartoletti M, Del Bono V, Corcione S, et al.; ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva). Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015 Jul 01;70(7):2133–2143. https://doi.org/10.1093/jac/dkv086TumbarelloMTrecarichiEMDe RosaFGGiannellaMGiacobbeDRBassettiMLositoARBartolettiMDel BonoVCorcioneSISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva).Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother.2015Jul 01;70(7):2133–2143. https://doi.org/10.1093/jac/dkv08610.1093/jac/dkv08625900159Search in Google Scholar
Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, et al. Predictors of mortality in bloodstream infections caused by Kleb siella pneumoniae carbapenemase-producing K. pneumoniae: impor tance of combination therapy. Clin Infect Dis. 2012 Oct 01;55(7):943–950. https://doi.org/10.1093/cid/cis588TumbarelloMVialePViscoliCTrecarichiEMTumiettoFMarcheseASpanuTAmbrettiSGinocchioFCristiniF, Predictors of mortality in bloodstream infections caused by Kleb siella pneumoniae carbapenemase-producing K. pneumoniae: impor tance of combination therapy. Clin Infect Dis.2012Oct 01;55(7):943–950. https://doi.org/10.1093/cid/cis58810.1093/cid/cis58822752516Search in Google Scholar
Turlej-Rogacka A, Xavier BB, Janssens L, Lammens C, Zarkotou O, Pournaras S, Goossens H, Malhotra-Kumar S. Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin. Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):345–353. https://doi.org/10.1007/s10096-017-3140-3Turlej-RogackaAXavierBBJanssensLLammensCZarkotouOPournarasSGoossensHMalhotra-KumarS.Evaluation of colistin stability in agar and comparison of four methods for MIC testing of colistin. Eur J Clin Microbiol Infect Dis.2018Feb;37(2):345–353. https://doi.org/10.1007/s10096-017-3140-310.1007/s10096-017-3140-3578053029177612Search in Google Scholar
U.S. National Library of Medicine. A study of meropenem-vaborbactam versus piperacillin/tazobactam in participants with hospital-acquired and ventilator-associated bacterial pneumonia (TANGOIII). https://clinicaltrials.gov/ct2/show/NCT03006679U.S. National Library of Medicine.A study of meropenem-vaborbactam versus piperacillin/tazobactam in participants with hospital-acquired and ventilator-associated bacterial pneumonia (TANGOIII). https://clinicaltrials.gov/ct2/show/NCT03006679Search in Google Scholar
van Rennings L, von Münchhausen C, Ottilie H, Hartmann M, Merle R, Honscha W, Käsbohrer A, Kreienbrock L. Cross-sectional study on antibiotic usage in pigs in Germany. PLoS ONE. 2015; 0(3): e0119114. https://doi.org/10.1371/journal.pone.0119114van RenningsLvon MünchhausenCOttilieHHartmannMMerleRHonschaWKäsbohrerAKreienbrockL.Cross-sectional study on antibiotic usage in pigs in Germany. PLoS ONE.2015; 0(3): e0119114. https://doi.org/10.1371/journal.pone.011911410.1371/journal.pone.0119114436497725785688Search in Google Scholar
Vasoo S. Susceptibility testing for the polymyxins: two steps back, three steps forward? J Clin Microbiol. 2017;55(9):2573–2582. https://doi.org/10.1128/JCM.00888-17VasooS.Susceptibility testing for the polymyxins: two steps back, three steps forward?J Clin Microbiol.2017;55(9):2573–2582. https://doi.org/10.1128/JCM.00888-1710.1128/JCM.00888-17564869428724555Search in Google Scholar
Vicari G, Bauer SR, Neuner EA, Lam SW. Association between colistin dose and microbiologic outcomes in patients with multidrugresistant Gram-negative bacteremia. Clin Infect Dis. 2013;56:398–404. https://doi.org/10.1093/cid/cis909VicariGBauerSRNeunerEALamSW.Association between colistin dose and microbiologic outcomes in patients with multidrugresistant Gram-negative bacteremia. Clin Infect Dis.2013;56:398–404. https://doi.org/10.1093/cid/cis90910.1093/cid/cis90923090926Search in Google Scholar
Walkty A, DeCorby M, Nichol K, Karlowsky JA, Hoban DJ, Zhanel GG. In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007–2008. Antimicrob Agents Chemother. 2009 Nov 01;53(11):4924–4926. https://doi.org/10.1128/AAC.00786-09WalktyADeCorbyMNicholKKarlowskyJAHobanDJZhanelGG.In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007–2008. Antimicrob Agents Chemother.2009Nov 01;53(11):4924–4926. https://doi.org/10.1128/AAC.00786-0910.1128/AAC.00786-09277231919704135Search in Google Scholar
Wang X, Wang Y, Zhou Y, Li J, Yin W, Wang S, Zhang S, Shen J, Shen Z, Wang Y. Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae. Emerg Microbes Infect. 2018 Dec;7(1):1–9. https://doi.org/10.1038/s41426-018-0124-zWangXWangYZhouYLiJYinWWangSZhangSShenJShenZWangY.Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae. Emerg Microbes Infect.2018Dec;7(1):1–9. https://doi.org/10.1038/s41426-018-0124-z10.1038/s41426-018-0124-z603010729970891Search in Google Scholar
Xavier BB, Lammens C, Ruhal R, Kumar-Singh S, Butaye P, Goossens H, Malhotra-Kumar S. Identification of a novel plasmid-madiated colistin-resistance gene, mcr-2, in Escherichia coli. Euro Surveill. 2016;21(27):30280. https://doi.org/10.2807/1560-7917.ES.2016.21.27.30280XavierBBLammensCRuhalRKumar-SinghSButayePGoossensHMalhotra-KumarS.Identification of a novel plasmid-madiated colistin-resistance gene, mcr-2, in Escherichia coli. Euro Surveill.2016;21(27):30280. https://doi.org/10.2807/1560-7917.ES.2016.21.27.3028010.2807/1560-7917.ES.2016.21.27.3028027416987Search in Google Scholar
Yang Y-Q, Li Y-X, Lei C-W, Zhang A-Y, Wang H-N. 2018. Novel plasmid mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae. J Antimocrob Chemother. 73(7):1791–1795. https://doi.org/10.1093/jac/dky111YangY-QLiY-XLeiC-WZhangA-YWangH-N.2018. Novel plasmid mediated colistin resistance gene mcr-7.1 in Klebsiella pneumoniae. J Antimocrob Chemother.73(7):1791–1795. https://doi.org/10.1093/jac/dky11110.1093/jac/dky11129912417Search in Google Scholar
Yin W, Li H, Shen Y, Liu Z, Wang S, Shen Z, Zhang R, Walsh RT, Shen J, Wang Y. 2017. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio. 8:e0054317. https://doi.org/10.1128/mBio.00543-17YinWLiHShenYLiuZWangSShenZZhangRWalshRTShenJWangY.2017. Novel plasmid-mediated colistin resistance gene mcr-3 in Escherichia coli. MBio.8:e0054317. https://doi.org/10.1128/mBio.00543-1710.1128/mBio.00543-17548772928655818Search in Google Scholar
Zhanel GG, Lawson CD, Adam H, Schweizer F, Zelenitsky S, Lagacé-Wiens PR, Denisuik A, Rubinstein E, Gin AS, Hoban DJ, et al. Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. Drugs. 2013;73(2):159–77. https://doi.org/10.1007/s40265-013-0013-7ZhanelGGLawsonCDAdamHSchweizerFZelenitskySLagacé-WiensPRDenisuikARubinsteinEGinASHobanDJ, Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination. Drugs.2013;73(2):159–77. https://doi.org/10.1007/s40265-013-0013-710.1007/s40265-013-0013-723371303Search in Google Scholar
Zhang H, Zhao D, Quan J, Hua X, Yu Y. mcr-1 facilitated selection of high-level colistin-resistant mutants in Escherichia coli. Clin Microbiol Infect. 2019;25(4):517.e1–517.e4. https://doi.org/10.1016/j.cmi.2018.12.014ZhangHZhaoDQuanJHuaXYuY.mcr-1 facilitated selection of high-level colistin-resistant mutants in Escherichia coli. Clin Microbiol Infect.2019;25(4):517.e1–517.e4. https://doi.org/10.1016/j.cmi.2018.12.01410.1016/j.cmi.2018.12.01430557703Search in Google Scholar
Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, Xie L, Yang C, Ma X, Li H, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network. Antimicrob Agents Chemother. 2018;62(2): e01882-17. https://doi.org/10.1128/AAC.01882-17ZhangYWangQYinYChenHJinLGuBXieLYangCMaXLiH, Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network. Antimicrob Agents Chemother.2018;62(2): e01882-17. https://doi.org/10.1128/AAC.01882-1710.1128/AAC.01882-17578681029203488Search in Google Scholar
Zhon HW, Zhang T, Ma JH, Fang Y, Wang HY, Huang ZX, Wang Y, Wu C, Chen GX. Occurrence of plasmid- and chromosome-carried mcr-1 in water-borne Enterobacteriaceae in China. Antimicrob Agents Chemother. 2017;61(8):e00017-17. https://doi.org/10.1128/AAC.00017-17ZhonHWZhangTMaJHFangYWangHYHuangZXWangYWuCChenGX.Occurrence of plasmid- and chromosome-carried mcr-1 in water-borne Enterobacteriaceae in China. Antimicrob Agents Chemother.2017;61(8):e00017-17. https://doi.org/10.1128/AAC.00017-1710.1128/AAC.00017-17552762128559252Search in Google Scholar
Zou D, Huang S, Lei H, Yang Z, Su Y, He X, Zhao Q, Wang Y, Liu W, Huang L. Sensitive and rapid detection of the plasmid-encoded colistin-resistance gene mcr-1 in Enterobacteriaceae isolates by loop-mediated isothermal amplification. Front Microbiol. 2017;8:2356. https://doi.org/10.3389/fmicb.2017.02356ZouDHuangSLeiHYangZSuYHeXZhaoQWangYLiuWHuangL.Sensitive and rapid detection of the plasmid-encoded colistin-resistance gene mcr-1 in Enterobacteriaceae isolates by loop-mediated isothermal amplification. Front Microbiol.2017;8:2356. https://doi.org/10.3389/fmicb.2017.0235610.3389/fmicb.2017.02356571254829238331Search in Google Scholar
Zurfuh K, Poirel L, Nordmann P, Nuesch-Inderbinen M, Hachler H, Stefan R. Occurrence of the plasmid-borne mcr-1 colistin resistance gene in extended-spectrum-beta-lactamase-producing Enterobacteriaceae in river water and imported vege tables was identified in Switzerland. Antimicrob Agents Chemother. 2016;60(4):2594–2595. https://doi.org/10.1128/AAC.00066-16ZurfuhKPoirelLNordmannPNuesch-InderbinenMHachlerHStefanR.Occurrence of the plasmid-borne mcr-1 colistin resistance gene in extended-spectrum-beta-lactamase-producing Enterobacteriaceae in river water and imported vege tables was identified in Switzerland. Antimicrob Agents Chemother.2016;60(4):2594–2595. https://doi.org/10.1128/AAC.00066-1610.1128/AAC.00066-16480820326883696Search in Google Scholar
